Attached files

file filename
S-1/A - AMENDMENT NO. 2 TO FORM S-1 - PUMA BIOTECHNOLOGY, INC.d416331ds1a.htm
EX-23.1 - CONSENT OF PKF CERTIFIED PUBLIC ACCOUNTANTS - PUMA BIOTECHNOLOGY, INC.d416331dex231.htm

Exhibit 5.1

 

            650 Town Center Drive, 20th Floor
      Costa Mesa, California 92626-1925
      Tel: +1.714.540.1235 Fax: +1.714.755.8290
      www.lw.com
LOGO                                                                                          FIRM / AFFILIATE OFFICES
      Abu Dhabi    Moscow
      Barcelona    Munich
      Beijing    New Jersey
      Boston    New York
      Brussels    Orange County
      Chicago    Paris
      Doha    Riyadh
      Dubai    Rome
      Frankfurt    San Diego
      Hamburg    San Francisco
      Hong Kong    Shanghai
      Houston    Silicon Valley
      London    Singapore
      Los Angeles    Tokyo
October 17, 2012       Madrid    Washington, D.C.
      Milan   
      File No. 048623-0003

Puma Biotechnology, Inc.

10880 Wilshire Boulevard, Suite 2150

Los Angeles, CA 90024

 

  Re: Registration Statement No. 333-184187; $115,862,000 of shares of
       common stock, par value $0.0001 per share

Ladies and Gentlemen:

We have acted as special counsel to Puma Biotechnology, Inc., a Delaware corporation (the “Company”), in connection with the proposed issuance of up to $115,862,000 of shares of common stock, $0.0001 par value per share, of the Company (the “Shares”) (including shares subject to the underwriters’ overallotment option). The Shares are included in a registration statement on Form S-1 under the Securities Act of 1933, as amended (the “Act”), filed with the Securities and Exchange Commission (the “Commission”) on September 28, 2012 (File No. 333-184187), as amended (the “Registration Statement”). The term “Shares” shall include any additional shares of common stock registered by the Company pursuant to Rule 462(b) under the Act in connection with the offering contemplated by the Registration Statement. This opinion is being furnished in connection with the requirements of Item 601(b)(5) of Regulation S-K under the Act, and no opinion is expressed herein as to any matter pertaining to the contents of the Registration Statement or related Prospectus, other than as expressly stated herein with respect to the issue of the Shares.

As such counsel, we have examined such matters of fact and questions of law as we have considered appropriate for purposes of this letter. With your consent, we have relied upon certificates and other assurances of officers of the Company and others as to factual matters without having independently verified such factual matters. We are opining herein as to the General Corporation Law of the State of Delaware and we express no opinion with respect to any other laws.


October 17, 2012

Page 2

LOGO

 

Subject to the foregoing and the other matters set forth herein, it is our opinion that, as of the date hereof, when the Shares shall have been duly registered on the books of the transfer agent and registrar therefor in the name or on behalf of the purchasers, and the Shares have been issued by the Company against payment therefor (not less than par value) in total numbers that do not exceed the total number of shares available under the Company’s certificate of incorporation and in the circumstances contemplated by the form of underwriting agreement most recently filed as an exhibit to the Registration Statement, the issue and sale of the Shares will have been duly authorized by all necessary corporate action of the Company, and the Shares will be validly issued, fully paid and nonassessable. In rendering the foregoing opinion, we have assumed that the Company will comply with all applicable notice requirements regarding uncertificated shares provided in the General Corporation Law of the State of Delaware.

This opinion is for your benefit in connection with the Registration Statement and may be relied upon by you and by persons entitled to rely upon it pursuant to the applicable provisions of the Act. We consent to your filing this opinion as an exhibit to the Registration Statement and to the reference to our firm in the Prospectus under the heading “Validity of Common Stock.” We further consent to the incorporation by reference of this letter and consent into any registration statement filed pursuant to Rule 462(b) with respect to the Shares. In giving such consent, we do not thereby admit that we are in the category of persons whose consent is required under Section 7 of the Act or the rules and regulations of the Commission thereunder.

Very truly yours,

/s/ Latham & Watkins LLP